4029 |
TAVR Long-Term Durability: Is It Concerned for Late-Catch Up in PARTNER-3? |
Martin Bert Leon |
Aug. 06. 20 |
4028 |
My Challenging MitraClip Case of the Year |
Saibal Kar |
Aug. 06. 20 |
4027 |
Developing COVID-19 Vaccines at Pandemic Speed: Potential Vaccine Platform |
Kayvon Modjarrad |
Aug. 06. 20 |
4026 |
Anti-Viral Drugs and Therapies: Hydroxychloroquine, Remdesivir, Plasma, and Others |
Jonathan Grein |
Aug. 06. 20 |
4025 |
Updated Evidence for Left Main PCI vs. CABG: Expert Cardiac Surgeon\'s Perspective |
David Paul Taggart |
Aug. 06. 20 |
4024 |
Long-term(10-Year) Validation of the SYNTAX-II 2020 Score |
Patrick W. Serruys |
Aug. 06. 20 |
4023 |
EXCEL Trial: Extended Long-term and Key Clinical Substudies |
Gregg W. Stone |
Aug. 06. 20 |
4022 |
My Challenging Bifurcation PCI Case of the Year |
Thierry Lefevre |
Aug. 06. 20 |
4021 |
East-Asian Paradox for Antithrombotics: Theory, Evidence and Next Strategy |
Duk-Woo Park |
Aug. 06. 20 |
4020 |
Short DAPT Strategy in the Contemporary PCI Era: Routine or Selective? |
Robert W. Yeh |
Aug. 06. 20 |